{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T18:25:55Z","timestamp":1750098355654,"version":"3.37.3"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T00:00:00Z","timestamp":1667174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T00:00:00Z","timestamp":1667174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-022-02436-x","type":"journal-article","created":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T17:04:07Z","timestamp":1667235847000},"page":"795-798","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Occult squamous cell carcinoma within lichenoid dermatitis: three examples of cryptic cancer detection"],"prefix":"10.1007","volume":"315","author":[{"given":"W. Clark","family":"Lambert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohan R.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muriel W.","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3036-3825","authenticated-orcid":false,"given":"Robert A.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,31]]},"reference":[{"key":"2436_CR1","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1111\/j.1524-4725.1997.tb00438.x","volume":"23","author":"RA Schwartz","year":"1997","unstructured":"Schwartz RA (1997) Actinic keratosis: perspective and update. Dermatol Surg 23:1009\u20131019","journal-title":"Dermatol Surg"},{"key":"2436_CR2","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1440-0960.2010.00624.x","volume":"51","author":"KK Siang","year":"2010","unstructured":"Siang KK, Wong S, Oliver GF (2010) Metastatic Merkel cell carcinoma with an unknown primary tumor presenting as lichenoid dermatitis. Australasian J Dermatol 51:202\u2013205","journal-title":"Australasian J Dermatol"},{"key":"2436_CR3","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.jaad.2015.10.029","volume":"74","author":"SJ Huang","year":"2016","unstructured":"Huang SJ, Carlos G, Wakade D et al (2016) Cutaneous adverse events (AEs) of anti-programmed cell death (anti-PD-1) therapy in patients with metastatic melanoma: a single-institution report. J Amer Acad Dermatol 74:455\u2013471","journal-title":"J Amer Acad Dermatol"},{"key":"2436_CR4","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1158\/2326-6066.CIR-14-0134","volume":"3","author":"RW Joseph","year":"2015","unstructured":"Joseph RW, Cappal M, Goedjen B et al (2015) Lichenoid dermatitis in three patients with metastatic melanoma treated with anti-PD-1 therapy. Cancer Immunol Res 3:18\u201322","journal-title":"Cancer Immunol Res"},{"key":"2436_CR5","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1634\/theoncologist.2019-0796","volume":"25","author":"AH Ameri","year":"2020","unstructured":"Ameri AH, Foreman RK, Vedak P, Chen S, Miller DM, Demehri S (2020) Hypertrophic lichen planus with histological features of squamous cell carcinoma associated with immune checkpoint blockade therapy. Oncologist 25:366\u2013368","journal-title":"Oncologist"},{"key":"2436_CR6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/DAD.0000000000000688","volume":"39","author":"MT Tetzlaff","year":"2017","unstructured":"Tetzlaff MT, Nagarajan P, Chon S et al (2017) Lichenoid dermatologic toxicity from immune checkpoint blockade therapy: a detailed examination of the clinicopathologic features. Am J Dermatopathol 39:121\u2013129","journal-title":"Am J Dermatopathol"},{"key":"2436_CR7","first-page":"636","volume":"4","author":"NM Fontecilla","year":"2018","unstructured":"Fontecilla NM, Kittler NW, Lopez A et al (2018) Programmed cell death protein-1 inhibitor induced granuloma annulare and hypertrophic lichen planus masquerading as squamous cell carcinoma. J Amer Acad Dermatol Case Rep 4:636\u2013639","journal-title":"J Amer Acad Dermatol Case Rep"},{"key":"2436_CR8","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1001\/jamadermatol.2016.2226","volume":"152","author":"VJ Shi","year":"2016","unstructured":"Shi VJ, Rodic N, Gettinger S et al (2016) Clinical and histologic features of lichenoid mucocutaneous eruptions due to anti-programmed cell death 1 and anti-cell death ligand 1 immunotherapy. JAMA Dermatol 152:1128\u20131136","journal-title":"JAMA Dermatol"},{"key":"2436_CR9","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1111\/cup.13739","volume":"47","author":"ML Marques-Piribelli","year":"2020","unstructured":"Marques-Piribelli ML, Tetzlaff MT, Priyadharsini P, Duke TC, Olivia ICG, Ledesma DA, Aung PP, Torres-Cabala CA, Wistuba II, Prieto VG, Nelson KC, Curry JL (2020) Hypertrophic lichenoid dermatitis immune-related adverse event during combined immune checkpoint and exportin inhibitor therapy: a diagnostic pitfall for superficially invasive squamous cell carcinoma. J Cutan Pathol 47:954\u2013959","journal-title":"J Cutan Pathol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-022-02436-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-022-02436-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-022-02436-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T11:04:00Z","timestamp":1681124640000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-022-02436-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,31]]},"references-count":9,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["2436"],"URL":"https:\/\/doi.org\/10.1007\/s00403-022-02436-x","relation":{},"ISSN":["1432-069X"],"issn-type":[{"type":"electronic","value":"1432-069X"}],"subject":[],"published":{"date-parts":[[2022,10,31]]},"assertion":[{"value":"1 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors report no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was not required for this study: Individuals are not identifiable from clinical data or histopathology.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}